Chronic Stable Angina Clinical Trial
Official title:
Allopurinol as a Possible New Therapy for Acute Coronary Syndromes:The Next Steps
Allopurinol is a drug commonly used to treat gout. However recent studies have shown it has the potential to help improve oxygen supply to heart muscle. In this study the Investigators aim to find out if allopurinol slows down the onset of angina symptoms, as seen by a doctor on a tracing of the heart (ECG- electrocardiogram), for patients who have been diagnosed with heart disease, when exercising on a treadmill. The Investigators are also are trying to figure out the best dose of allopurinol to use and to see how quickly it begins working. To do this the investigators will recruit patients with angina, exercise them on a treadmill after giving different doses of allopurinol and see if there is an improvement in their time to bring on angina symptoms and signs. Patients recruited to this trial will receive three different treatment regimes over a six week period. Each treatment regime will last for one week with a one week rest period between each regime. This will involve up to eleven visits to Ninewells Medical School, Dundee for testing.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02908776 -
MYocardial DAmage AND MIcrobiota STUDY
|
N/A | |
| Recruiting |
NCT01397994 -
Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.
|
Phase 4 | |
| Active, not recruiting |
NCT00350922 -
A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina
|
Phase 1 | |
| Completed |
NCT02078921 -
The Effects of Inorganic Nitrate on Cardiac Muscle in Angina
|
Phase 2 | |
| Completed |
NCT02591758 -
Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy
|
||
| Terminated |
NCT03346278 -
Text Message Intervention to Improve Cardiac Rehab Participation
|
N/A | |
| Active, not recruiting |
NCT06249581 -
Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions
|
Early Phase 1 | |
| Enrolling by invitation |
NCT03063697 -
Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure
|
N/A | |
| Completed |
NCT01239511 -
Phase IIb Study of STA-2 in Patients With Chronic Stable Angina
|
Phase 2 | |
| Completed |
NCT02722213 -
Mindfulness & Stress Management Study for Cardiac Patients
|
N/A | |
| Completed |
NCT01484912 -
Phase II Study of STA-2 in Patients With Chronic Stable Angina
|
Phase 2 | |
| Recruiting |
NCT03507361 -
Myocardial Damage and Music Study
|
N/A | |
| Recruiting |
NCT03834155 -
Enhancing Cardiac Rehabilitation Through Behavioral Nudges
|
N/A | |
| Active, not recruiting |
NCT02710435 -
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
|
||
| Withdrawn |
NCT00518921 -
Capadenoson in Angina Pectoris
|
Phase 2 | |
| Withdrawn |
NCT02423265 -
Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries
|
Phase 4 | |
| Completed |
NCT01369472 -
Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule
|
Phase 1 | |
| Completed |
NCT01340248 -
A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers
|
Phase 1 | |
| Completed |
NCT02315001 -
Liraglutide to Improve corONary Haemodynamics During Exercise streSS
|
Phase 2 | |
| Completed |
NCT01760083 -
A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions
|
N/A |